SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0000950133-02-002118
Filing Date
2002-05-24
Accepted
2002-05-24 17:26:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFC14A w61086defc14a.txt DEFC14A 57214
  Complete submission text file 0000950133-02-002118.txt   59119
Mailing Address 28101 N. BALLARD DR. SUITE F LAKE FOREST IL 60045
Business Address 28101 N. BALLARD DR. SUITE F LAKE FOREST IL 60045 847-573-8990
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 000-16929 | Film No.: 02662779
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 210 CENTRAL PARK SOUTH NEW YORK NY 10019
KANZER STEVE H (Filed by) CIK: 0001076653 (see all company filings)